No Substitution. Institution and Principal Investigator may not reassign the conduct of the Trial to a different Principal Investigator without prior written authorization from Sponsor. Any replacement Principal Investigator will be required to agree to the terms and conditions of this Agreement in a separate writing. In the event Sponsor does not approve a replacement Principal Investigator, Sponsor or CRO may terminate this Agreement in accordance with the Termination provisions below. 1.4.
No Substitution. This Schedule shall be construed consistently with but does not substitute for any requirements or procedures in relation to Aboriginal consultation or the Section 35 Duty that may be imposed by a ministry, board, agency or other regulatory decision-maker acting pursuant to laws and regulations. Such decision-makers may have additional obligations or requirements. Nonetheless, the intent of Ontario is to promote coordination among provincial ministries, boards and agencies with roles in consulting with Aboriginal Groups so that the responsibilities outlined in this Agreement may be fulfilled efficiently and in a manner that avoids, to the extent possible, duplication of effort by Aboriginal Groups, the Recipient, Ontario, and provincial ministries, boards, agencies and other regulatory decision-makers.
No Substitution. No Contract provides for the substitution, exchange or addition of any Financed Vehicle subject to such Contract.
No Substitution. Institution and Principal Investigator may not reassign the conduct of the Trial to a different Principal Investigator without prior written authorization from Sponsor. Any replacement Principal Investigator will be required to agree to the terms and conditions of this Agreement in a separate writing. In the event Sponsor does not approve a replacement Principal Investigator, Sponsor or Syneos Health may terminate this Agreement in accordance with the Termination provisions below. 1.4. Zákaz zastupování Zdravotnické zařízení a hlavní zkoušející nesmí postoupit provádění klinického hodnocení na jiného hlavního zkoušejícího bez předchozího písemného schválení zadavatele. Náhradní hlavní zkoušející bude muset vyjádřit souhlas s podmínkami této smlouvy v písemném dokumentu. V případě, že zadavatel neschválí náhradního hlavního zkoušejícího, může zadavatel nebo společnost Syneos Health v souladu s dále uvedenými podmínkami ukončení platnosti smlouvy smlouvu ukončit.
No Substitution. Provider and Principal Investigator may not reassign the conduct of the Trial to a different Principal Investigator without prior written authorization from Sponsor. Any replacement Principal Investigator will be required to agree to the terms and conditions of this Agreement in a separate writing. In the event Sponsor does not approve a replacement Principal Investigator, CRO may terminate this Agreement or CRO per Sponsor’s request may terminate in accordance with the Termination provisions below. 1.4.
No Substitution. No substitution of materials, equipment, articles or processes required specifically identified in the Contract Documents will be made without written approval of Owner's Project Manager.
No Substitution. The Obligor under such Receivable does not have the unilateral right to substitute, exchange or add any Financed Vehicle under such Receivable.
No Substitution. Prizes may not be substituted or exchanged by Winner. No cash settlement will be awarded on any prize.
No Substitution. This Agreement may but need not be supplemented by separate assignments and pledges and, if such assignments and pledges are given, the rights and security interests given thereby shall be in addition to and not in limitation of the rights and security interests given by this Agreement. This Agreement shall not act to terminate, cancel, revoke, nor otherwise cause a novation, estoppel, or waiver of any or all prior security interests granted by Borrower to Lender in and to any collateral contemplated by these presents, or other, wholly or in part, and without exception; and any and all such security interests shall continue to remain properly perfected by Borrower to Lender in their terms and without interruption.
No Substitution. Nothing contained in Section 8.1 shall be construed to represent a substitution for compensation already paid to or earned by Executive. In addition, Executive shall be entitled to receive all amounts in respect of the period prior to the date of termination otherwise payable herein (without double counting), including such payments provided for in Sections 4 and 5.
